A Novel Targeted Therapy for Glaucoma/ITRI
A novel eye drop for glaucoma, with three key features addressing these issues. First, this innovative eye drop features a dual-target mechanism, ensuring patients’ proper outflow of aqueous humor from their eyes to relieve the built-up eye pressure. Second, pre-clinical trials have validated its efficacy in reducing eye pressure, not just for glaucoma patients but also for individuals with elevated intraocular pressure. Third, this eye drop also stands out for its safety.